Results 251 to 260 of about 795,110 (304)

HLA‐A9 antibodies and epitopes

Tissue Antigens, 1996
Fifty pregnancy alloantisera directed towards HLA‐A23 and/or A24 antigens were investigated serologically in titration studies against the three sequenced HLA‐A9 specificities, A23 (A*2301), A24 (A*2402) and A2403 (A*2403). The reaction patterns of the antisera fell into five categories which allowed the three HLA‐A9 specificities to be easily ...
H, Fussell, M, Thomas, J, Street, C, Darke   +3 more
openaire   +2 more sources

Monoclonal Antibody to HLA-A3

Hybridoma, 1982
The monoclonal antibody GAP A3 detects the HLA allospecificity A3. Reactivity of the monoclonal was in exact concordance with the presence of the A3 antigen as defined by conventional alloantisera on a panel of 59 cells from individuals with well-characterized HLA antigens.
A E, Berger, J E, Davis, P, Cresswell
openaire   +2 more sources

The dilemma of DQ HLA-antibodies

Human Immunology, 2015
Accurate identification of antibody reactivity against HLA-DQ antigens was difficult by using the old serological assays because of the strong linkage disequilibrium between HLA-DR and HLA-DQ (the usual inheritance of a certain HLA-DR molecule that ties together with the same DQ molecule within a racial group).
Rabab, Al Attas, Dalal, Al Abduladheem, Adel A, Shawhatti, Ricardo, Lopez, Abdelhamid, Liacini, Saber, AlZahrani, Khalid, Akkari, Nasreen, Hasan, Abdulnaser, Alabadi   +8 more
openaire   +2 more sources

Monoclonal Antibodies to HLA-B27

Rheumatology, 1983
Because HLA-B27 is such an important genetic marker for susceptibility to spondyloarthropathies and other related diseases, study of this alloantigen was undertaken using murine monoclonal antibodies. The first monoclonal anti-B27 antibody, B27M1, is an IgG2a lymphocytotoxic antibody that reacts with all B27 antigens and cross-reacts to a lesser degree
openaire   +2 more sources

Is Serum the Optimal Source for HLA Antibodies?

Vox Sanguinis, 1987
Abstract. The cytotoxic reactivity of 18 predefined class I HLA serum antibodies was compared with that of antibody preparations containing anticoagulants. ACD‐A, EDTA, 4% citrate and heparin plasmas all showed lower cytotoxicity than serum antibodies.
D, Gardell, B, Gormley, H, Mervart, G, Rock   +3 more
openaire   +2 more sources

Anti-HLA antibodies in heart transplantation

Transplant Immunology, 2004
We have analyzed the relationship between the development of transplant-related coronary artery disease (TRCAD) and the following potential risk factors: (a). number of HLA mismatches between recipient and donor; (b). production of anti-HLA antibodies; (c). growth of lymphocytes infiltrating the graft; and (d).
Elena R, Vasilescu, Eric K, Ho, Ludwika, de la Torre, Silviu, Itescu, Charles, Marboe, Raffaello, Cortesini, Nicole, Suciu-Foca, Donna, Mancini   +7 more
openaire   +2 more sources

HLA monoclonal antibody registry: a proposal

Tissue Antigens, 1982
A review of the literature and discussions at the preliminary meeting of the 9th International Histocompatibility Workshop (Munich, March 1982) have highlighted the growing importance of HLA monoclonal antibodies (McAb) for immunogenetic, biochemical and functional studies.
J, Colombani, J, Dausset, V, Lepage, L, Degos, J, Kalil, M, Fellous   +5 more
openaire   +2 more sources

HLA Antibodies, Non-HLA Antibodies, and Crossmatch Methods

1993
In the mid-1960s a number of reports were published showing a strong association between reactivity of antibodies in the patient’s pregraft serum with the lymphocytes of the donor (positive crossmatch) and immediate rejection of the renal allograft (hyperacute rejection) (Kissmeyer-Nielsen et al. 1966; Terasaki et al. 1968).
openaire   +1 more source

A monoclonal antibody to the HLA-A3 alloantigen

Immunology Letters, 1982
Monoclonal antibody production recognizing the HLA-A3 antigen is described. The XI-23 antibody reacted with all of the 89 cell suspensions carrying the HLA-A3 antigen (100% cytotoxicity) among a total of 191 suspensions tested. No extra-reactivity or cross-reactivity was observed, particularly with that of HLA-A11.
D, Bourel, R, Fauchet, B, Genetet, G, Merdrignac, D, Hurez   +4 more
openaire   +2 more sources

Renal retransplantation in patients with HLA-antibodies

Transplant International, 1992
The results of 92 consecutive renal retransplantations, performed during a 5-year period in recipients with HLA-antibodies, were retrospectively analysed. The actuarial 1-year graft survival (1-y GS) was 65% for all retransplantations, as compared with 63% for first grafts in sensitized recipients.
L, Mjörnstedt, J, Konar, G, Nyberg, M, Olausson, L, Sandberg, I, Karlberg   +5 more
openaire   +2 more sources